|
Market Closed -
OTC Markets
11:40:30 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +25.00% |
|
0.00% | - |
| 3 months | +25.00% |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0 | |
| 10 years | 0 | 0.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 2012-08-01 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 2009-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 2010-01-19 |
Steven Byle
BRD | Director/Board Member | 58 | 2009-11-08 |
Roger Fidler
BRD | Director/Board Member | 75 | 2009-12-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +25.00% | 0.00% | - | - | 0 | ||
| -0.87% | -3.94% | +37.45% | -2.73% | 81.36B | ||
| -4.60% | -18.13% | +477.32% | +27.55% | 59.75B | ||
| +0.84% | +4.44% | -19.19% | -35.11% | 59.19B | ||
| +0.76% | +3.53% | +0.08% | +36.18% | 53.33B | ||
| +0.41% | +1.88% | +11.09% | +171.67% | 49.09B | ||
| +0.19% | -0.03% | +62.01% | -16.23% | 32.66B | ||
| -0.30% | -0.57% | +52.07% | +100.03% | 25.97B | ||
| -2.00% | +9.52% | +12.38% | +218.34% | 24.39B | ||
| +0.78% | +0.47% | +61.53% | +123.40% | 16.91B | ||
| Average | +2.42% | +0.14% | +77.19% | +69.23% | 40.26B | |
| Weighted average by Cap. | -0.09% | -1.01% | +88.66% | +47.64% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
















